GENEVA, Feb. 24 -- AC IMMUNE SA (EPFL Innovation Park, Building B1015 Lausanne) filed a patent application (PCT/EP2024/073102) for "DIAGNOSTIC COMPOUNDS THAT BIND TO ALPHA-SYNUCLEIN" on Aug 16, 2024. With publication no. WO/2025/037013, the details related to the patent application was published on Feb 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MOLETTE, Jerome (EPFL Innovation Park, Building B1015 Lausanne)
Abstract:
The present application relates to novel compounds of formula (I), or a detectably labelled compound, stereoisomer, racemic mixture, pharmaceutically acceptable salt...